Connection

Michael Lilly to Receptor, IGF Type 1

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Receptor, IGF Type 1.
Michael Lilly
Connection Strength
0.225
Receptor, IGF Type 1
  1. SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol. 2015 May 10; 33(14):1601-8.
    View in: PubMed
    Score: 0.129
  2. Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels. Neoplasia. 2011 Feb; 13(2):108-19.
    View in: PubMed
    Score: 0.096
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.